Senate approves bill on drug regulation giving FDA new powers

With the bill's drug-import provision made moot, the Senate voted overwhelmingly to require the FDA to monitor drugs after they have gone to market and drugmakers to reveal trial data. The 93-1 vote sent the measure to the House where similar legislation is pending. The Senate version also would order changes in drug labels and advertising as well as support the FDA's new powers through additional user fees.

View Full Article in:

NYTimes.com · Washington Post (tiered subscription model), The · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID